Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease
- PMID: 27824652
- DOI: 10.1097/MIB.0000000000000946
Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease
Abstract
The pathophysiology of Crohn's disease (CD), a chronic inflammatory bowel disease, remains imperfectly elucidated. Consequently, the therapeutic armamentarium remains limited and has not changed the natural history of CD hitherto. Accordingly, physicians need to identify new therapeutic targets to be able to alter the intestinal damage. The most recent hypothesis considered CD as resulting from an abnormal interaction between microbiota and host immune system influenced by genetics and environmental factors. Several experimental and genetic evidence point out intestinal macrophages in CD etiology. An increase of macrophages number and the presence of granulomas are especially observed in the intestinal mucosa of patients with CD. These macrophages could be defective and particularly in responses to infectious agents like CD-associated Escherichia coli. This review focuses on, what is currently known regarding the role of macrophages, macrophages/E. coli interaction, and the impact of CD therapies on macrophages in CD. We also speculate that macrophages modulation could lead to important translational implications in CD with the end goal of promoting gut health.
Similar articles
-
Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease.World J Gastroenterol. 2014 Jul 21;20(27):8751-63. doi: 10.3748/wjg.v20.i27.8751. World J Gastroenterol. 2014. PMID: 25083050 Free PMC article. Review.
-
Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn's disease.BMC Gastroenterol. 2015 Jul 3;15:75. doi: 10.1186/s12876-015-0305-3. BMC Gastroenterol. 2015. PMID: 26137941 Free PMC article.
-
Defective macrophage handling of Escherichia coli in Crohn's disease.J Gastroenterol Hepatol. 2015 Aug;30(8):1265-74. doi: 10.1111/jgh.12955. J Gastroenterol Hepatol. 2015. PMID: 25809337
-
The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease.Dig Liver Dis. 2009 Feb;41(2):166-8. doi: 10.1016/j.dld.2008.09.012. Epub 2008 Nov 20. Dig Liver Dis. 2009. PMID: 19026604 Review.
-
Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease.Inflamm Bowel Dis. 2009 Jun;15(6):872-82. doi: 10.1002/ibd.20860. Inflamm Bowel Dis. 2009. PMID: 19235912
Cited by
-
In vivo Assessment of the Impact of Molecular Weight on Constructs of 68Ga-DOTA-Manocept in a Syngeneic Mouse Tumor Model.Mol Imaging Biol. 2023 Oct;25(5):867-874. doi: 10.1007/s11307-023-01809-6. Epub 2023 Mar 7. Mol Imaging Biol. 2023. PMID: 36882605 Free PMC article.
-
Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases.APMIS. 2022 Aug;130 Suppl 144(Suppl 144):1-38. doi: 10.1111/apm.13256. APMIS. 2022. PMID: 35899316 Free PMC article. No abstract available.
-
Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease.Microbiome. 2021 Aug 23;9(1):176. doi: 10.1186/s40168-021-01135-5. Microbiome. 2021. PMID: 34425887 Free PMC article.
-
Role of macrophage in nanomedicine-based disease treatment.Drug Deliv. 2021 Dec;28(1):752-766. doi: 10.1080/10717544.2021.1909175. Drug Deliv. 2021. PMID: 33860719 Free PMC article. Review.
-
Simkania negevensis in Crohn's Disease.Dig Dis Sci. 2019 Nov;64(11):3284-3290. doi: 10.1007/s10620-019-05632-4. Epub 2019 Apr 30. Dig Dis Sci. 2019. PMID: 31041636
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical